|[January 13, 2014]
Research and Markets: Global Gliosarcoma Clinical Trials Review, H2, 2013
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/6w87r9/gliosarcoma)
has announced the addition of the "Gliosarcoma
Global Clinical Trials Review, H2, 2013" report to their
This report provides elemental information and data relating to the
clinical trials on Gliosarcoma. It includes an overview of the trial
numbers and their recruitment status as per the site of trial conduction
across the globe. The databook offers a preliminary coverage of disease
cinical trials by their phase, trial status, prominence of the sponsors
and also provides briefing pertaining to the number of trials for the
key drugs for treating Gliosarcoma.
Data on the number of clinical trials conducted in North America,
South and Central America, Europe, Middle-East and Africa and
Asia-pacific and top five national contributions in each, along with
the clinical trial scenario in BRIC nations
Clinical trial (complete and in progress) data by phase, trial status,
subjects recruited and sponsor type
Listings of discontinued trials (suspended, withdrawn and terminated)
Top Companies Participating in Gliosarcoma Therapeutics Clinical
Arno Therapeutics, Inc.
Biogen Idec Inc.
Celldex Therapeutics, Inc.
Eli Lilly and Company
Merck & Co., Inc.
For more information visit http://www.researchandmarkets.com/research/6w87r9/gliosarcoma
[ Back To TMCnet.com's Homepage ]